Invention Grant
- Patent Title: Methods of treatment using anti-IL-17A/F antibodies
-
Application No.: US15771310Application Date: 2016-10-26
-
Publication No.: US11492396B2Publication Date: 2022-11-08
- Inventor: Sophie Glatt , Lucian Ionescu , Margaret Jones , Ruth Oliver , Stevan Graham Shaw , Foteini Strimenopoulou , Venkata Pavan Kumar Vajjah
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/EP2016/075821 WO 20161026
- International Announcement: WO2017/072183 WO 20170504
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61P17/06 ; A61P19/02 ; A61K39/00
Abstract:
The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
Public/Granted literature
- US20190292255A1 Methods of Treatment Using Anti-IL-17A/F Antibodies Public/Granted day:2019-09-26
Information query
